Clinical Trials on Transthyroxin Amyloidosis Cardiomyopathy in United Kingdom
Total 729 results
-
Wake Forest University Health SciencesRecruitingCardiac AmyloidosisUnited States
-
Dr Manvir Kaur HayerBritish Heart FoundationUnknownMyocardial Fibrosis | Chronic Kidney Diseases | Cardio-Renal Syndrome | Uraemic CardiomyopathyUnited Kingdom
-
Mayo ClinicCompletedPrimary Systemic AmyloidosisUnited States
-
Attralus, Inc.Novotech (Australia) Pty LimitedRecruitingAmyloidosis; SystemicUnited States, Australia
-
Royal National Orthopaedic Hospital NHS TrustUniversity College London HospitalsCompleted
-
University of PennsylvaniaFox Chase Cancer CenterCompletedCardiovascular Diseases | Cancer | Hereditary Cancer | Hereditary Cardiac AmyloidosisUnited States
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Sweden, Brazil, United States, France, Spain, Germany
-
Indiana UniversityAmerican Heart AssociationRecruitingCardiomyopathies | Dilated Cardiomyopathy | Hypertrophic Cardiomyopathy | Arrhythmogenic Right Ventricular Cardiomyopathy | Restrictive Cardiomyopathy | Left Ventricular Non-compaction CardiomyopathyUnited States
-
Royal Brompton & Harefield NHS Foundation TrustRecruitingCoronary Artery Disease | CardiomyopathyUnited Kingdom
-
Barts & The London NHS TrustQueen Mary University of LondonWithdrawnCardiomyopathies | COVID | Cardiovascular Disease AcuteUnited Kingdom
-
Sorrento Therapeutics, Inc.RecruitingLight Chain (AL) AmyloidosisUnited States
-
University of PittsburghGE HealthcareCompletedStress Induced CardiomyopathyUnited States
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCRecruitingAL Amyloidosis | Amyloid | Refractory AL AmyloidosisUnited States
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Spain, Sweden, Brazil, United States, France, Germany
-
Tufts Medical CenterTerminatedAL AmyloidosisUnited States
-
Celladon CorporationCompletedHeart Failure | Cardiomyopathies | Ischemic Cardiomyopathy | Non-ischemic CardiomyopathyUnited States, United Kingdom, Belgium, Germany, Poland, Israel, Netherlands, Hungary, Denmark, Sweden
-
Brigham and Women's HospitalBaylor College of Medicine; Duke University; National Human Genome Research Institute...CompletedHealthy Adults (Full Study and Extension Phase) | Hypertrophic Cardiomyopathy or Dilated CardiomyopathyUnited States
-
University of AberdeenActive, not recruiting
-
University of Missouri-ColumbiaTerminatedCardiomyopathyUnited States
-
Johns Hopkins UniversityCompletedHeart Failure | Ischemic Cardiomyopathy | Nonischemic CardiomyopathyUnited States
-
Prothena Biosciences Ltd.CompletedAL AmyloidosisUnited States, Spain, Australia, Germany, United Kingdom, France, Greece, Israel, Italy, Austria
-
Mayo ClinicRecruitingAL AmyloidosisUnited States
-
Columbia UniversityCephalonCompletedAL AmyloidosisUnited States
-
Ann Marie ChikowskiMain Line HealthCompletedDilated Cardiomyopathy | Congestive Heart Failure | Ischemic Congestive CardiomyopathyUnited States
-
Alfred Chung, MDAbbVie; Janssen PharmaceuticalsRecruitingAL Amyloidosis | Light Chain (AL) Amyloidosis | Systemic Light Chain DiseaseUnited States
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; National Cancer Institute (NCI); Multiple Myeloma Research...Active, not recruitingRecurrent Primary AmyloidosisUnited States
-
Icahn School of Medicine at Mount SinaiMillennium Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
Boston Medical CenterJanssen PharmaceuticalsCompleted
-
Andrew EisenbergerCompletedAmyloidosisUnited States
-
University of TennesseeFood and Drug Administration (FDA)Completed
-
Weill Medical College of Cornell UniversityU.S. Deprescribing Research NetworkRecruiting
-
Michael AyersBristol-Myers SquibbNot yet recruitingObstructive Hypertrophic CardiomyopathyUnited States
-
MyoKardia, Inc.CompletedDilated Cardiomyopathy | Heart Failure With Reduced Ejection FractionUnited States, France, United Kingdom, Sweden, Germany, Netherlands, Poland
-
Stanford UniversityCompletedAmyloidosis | Blood and Marrow Transplant (BMT)United States
-
Henry M. SpotnitzNational Heart, Lung, and Blood Institute (NHLBI)TerminatedDilated Cardiomyopathy | Ischemic CardiomyopathyUnited States
-
Bristol-Myers SquibbActive, not recruitingHypertrophic Cardiomyopathy | Non-obstructive Hypertrophic Cardiomyopathy | Obstructive Hypertrophic CardiomyopathyDenmark, United States, Belgium, Czechia, France, Germany, Israel, Italy, Netherlands, Poland, Portugal, Spain, United Kingdom
-
Duke UniversityTerminatedHypertrophic Cardiomyopathy | Non-ischemic Dilated Cardiomyopathy | Microvascular Ischaemia of MyocardiumUnited States
-
Mayo ClinicCompletedAmyloidosisUnited States
-
AbbVieRecruitingImmunoglobulin Light Chain (AL) AmyloidosisJapan, United States
-
Tufts Medical CenterCompletedMinimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL AmyloidosisAmyloidosis | Primary AmyloidosisUnited States
-
Rajshekhar Chakraborty, MDGenentech, Inc.RecruitingAL AmyloidosisUnited States
-
Boston Medical CenterCelgene CorporationCompletedAL AmyloidosisUnited States
-
Boston Medical CenterTerminatedAL AmyloidosisUnited States
-
University of TennesseeCompleted
-
Wayne State UniversityChildren's Hospital of Philadelphia; Washington University School of Medicine; National Heart, Lung, and Blood Institute (NHLBI) and other collaboratorsCompletedDilated Cardiomyopathy | Hypertrophic Cardiomyopathy | Restrictive CardiomyopathyUnited States, Canada
-
Joshua M HareNational Heart, Lung, and Blood Institute (NHLBI)CompletedNon-ischemic Dilated CardiomyopathyUnited States
-
Prothena Biosciences Ltd.TerminatedPrimary Systemic (AL) AmyloidosisUnited States, Spain, Israel, Canada, Poland, Netherlands, France, Germany, United Kingdom, Belgium, Denmark, Greece, Australia, Austria, Italy
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline; AstraZenecaCompletedIdiopathic Dilated CardiomyopathyUnited States
-
Cedars-Sinai Medical CenterWithdrawnIschemic Cardiomyopathy | Chronic Ischemic CardiomyopathyUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States, Canada